首页 | 本学科首页   官方微博 | 高级检索  
检索        

树突状细胞肿瘤疫苗用于胃癌免疫治疗的新进展
引用本文:宁敏曼,王立.树突状细胞肿瘤疫苗用于胃癌免疫治疗的新进展[J].医学综述,2006,12(4):200-202.
作者姓名:宁敏曼  王立
作者单位:重庆医科大学附属第一医院消化内科,重庆,410006
摘    要:树突状细胞(DCs)即是体内最有效的专业抗原提呈细胞,也是抗原特异性免疫应答的始动者,具有摄取、加工、递呈抗原至T淋巴细胞的能力,表达高水平的MHCⅠ、Ⅱ和CD80、CD86等共刺激分子,在免疫应答中起关键作用。以DCs为基础的各种疫苗在胃癌免疫治疗中取得了很大的成就。

关 键 词:胃肿瘤  树突状细胞  免疫治疗
文章编号:1006-2084(2006)04-0200-03
收稿时间:2005-07-13
修稿时间:2005-12-04

The Progress about Immunotherapy of Gastric Carcinoma Using Dendritic Cell Tumor Vaccines
NING Min-man,WANG Li.The Progress about Immunotherapy of Gastric Carcinoma Using Dendritic Cell Tumor Vaccines[J].Medical Recapitulate,2006,12(4):200-202.
Authors:NING Min-man  WANG Li
Institution:The Department of Digestive Disease of the First Affiliated Hospital of Chongqing Medical University, Chongqing 410006, China
Abstract:Dendritic cells are not only the most effective and professional antigen-presenting cells,but also the initiator of antigen-specific immune responses.They can capture,process and present antigens to T lymphocyte and highly express MHC-Ⅰ,MHC-Ⅱ and many other costimulatory molecules such as CD_(80)、CD_(86) and so on.Dendritic cells play a key role in immune responses.Moreover,various vaccines based on DC-achieved a significant success in gastric cancer immunotherapy.
Keywords:Stomach neoplasms  Dendritic cells  Immunotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号